![](https://www.diabetesnews.com/wp-content/uploads/2012/10/5089f3386cbd3.preview-620-150x150.jpg)
ViaCyte is developing a drug delivery system that enables implanted pancreatic progenitor cells to survive and differentiate into functioning insulin-producing islet cells.
Read more
ViaCyte is developing a drug delivery system that enables implanted pancreatic progenitor cells to survive and differentiate into functioning insulin-producing islet cells.
Read more